These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1803831)

  • 1. Immunologic recurrent abortion: comparison between immunotherapies.
    Perino A; Cimino C; Pignatone C; Borruso A; Chianchiano N; Bertolino G; Biondo A; Costa P; Cittadini E; Marcenò R
    Acta Eur Fertil; 1991; 22(3):171-5. PubMed ID: 1803831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives for the therapeutic management of recurrent immunological abortion.
    Perino A; Barba G; Cimino C; Costa P; Pignatone C; Scaglione G; Zangara C; Cittadini E; Marcenò R; Cavallaro AM
    Acta Eur Fertil; 1989; 20(6):359-62. PubMed ID: 2484960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Passive immunotherapy in risk of habitual abortion--the course of maternal serum immunoglobulins].
    Krümmer A; Römer T
    Zentralbl Gynakol; 1996; 118(1):33-6. PubMed ID: 8588449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
    Am J Reprod Immunol; 1994 Sep; 32(2):55-72. PubMed ID: 7826502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of intravenous immunoglobulin in sine causa or alloimmune recurrent spontaneous abortion (RSA).
    Patriarca A; Piccioni V; Gigante V; Benedetto C
    Panminerva Med; 2000 Sep; 42(3):193-5. PubMed ID: 11218624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface CD200 may predict efficacy of paternal mononuclear leukocyte immunotherapy in treatment of human recurrent pregnancy loss.
    Clark DA
    Am J Reprod Immunol; 2009 Jan; 61(1):75-84. PubMed ID: 19086995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunization with partner's lymphocytes of women subject to recurrent early spontaneous abortions].
    Soulier-Lauper M; Pichler W; Jeannet M; von Felten A; Brun del Re G
    Schweiz Med Wochenschr; 1989 Dec; 119(51):1854-8. PubMed ID: 2692148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic diagnosis and therapy in habitual abortion].
    Schwartz D; Jungl E; Neumeister A
    Wien Med Wochenschr; 1990; 140(22):547-50. PubMed ID: 2080628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
    Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
    Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin.
    Kotlan B; Padanyi A; Batorfi J; Fulop V; Szigetvari I; Rajczy K; Penzes M; Gyodi E; Reti M; Petranyi G
    Am J Reprod Immunol; 2006 May; 55(5):331-40. PubMed ID: 16635207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
    Pandey MK; Agrawal S
    Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age.
    Lambropoulou M; Tamiolakis D; Venizelos J; Liberis V; Galazios G; Tsikouras P; Karamanidis D; Petrakis G; Constantinidis T; Menegaki M; Papadopoulos N
    Clin Exp Med; 2006 Dec; 6(4):171-6. PubMed ID: 17191109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.
    Winger EE; Reed JL
    Am J Reprod Immunol; 2008 Jul; 60(1):8-16. PubMed ID: 18422811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Winger EE
    Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of three different therapeutic protocols according to the immunologic pathology present in three women with recurrent spontaneous abortion and fetal death for immunologic reasons: flucortolone and salicylates; high-dose intravenous gammaglobulins; subcutaneous heparin.
    Cimino C; Perino A; Barba G; Cittadini E; Marcenò R; Cavallaro AM; Indovina A
    Acta Eur Fertil; 1990; 21(4):177-83. PubMed ID: 1707572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Idiopathic habitual abortion. Immunologic causes and immune stimulatory therapy].
    Christiansen OB; Georgsen J; Reiche T
    Ugeskr Laeger; 1987 Feb; 149(7):445-9. PubMed ID: 3469809
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of leukocyte immunotherapy in primary recurrent spontaneous abortion (RSA).
    Gharesi-Fard B; Zolghadri J; Foroughinia L; Tavazoo F; Samsami Dehaghani A
    Iran J Immunol; 2007 Sep; 4(3):173-8. PubMed ID: 17767017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of habitual abortion by vaccinating women with the husband's lymphocytes].
    Uhrynowska M; Zupańska B
    Ginekol Pol; 1989 Feb; 60(2):132. PubMed ID: 2806963
    [No Abstract]   [Full Text] [Related]  

  • 19. Active or passive immunization in unexplained recurrent miscarriage.
    Christiansen OB; Nielsen HS; Pedersen B
    J Reprod Immunol; 2004 Jun; 62(1-2):41-52. PubMed ID: 15288180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent pregnancy loss related to immune disorders].
    Ksouri H; Zitouni M; Achour W; Makni S; Ben Hassen A
    Ann Med Interne (Paris); 2003 Sep; 154(4):233-47. PubMed ID: 14593313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.